NVO
R500#88 today
$39.40
+3.36% today · +3.20% 1W
Oct 15 close or latest
ReadoutWhy it's moving
Weight-loss stocks rise on obesity pipeline optimism
- NVO +3.36% on the last session vs SPY +0.04%: +3.3 pts of stock-specific move.
- Weight-loss drugs: VKTX clocked its best day in nearly 3 months on obesity pipeline optimism and buyout speculation, per Stocktwits. (Stocktwits)
- Weight-loss drugs basket +5.2% (+5.1 pts vs SPY; VKTX +5.3%, LLY +5.0%): the stock moved with its peers.
- Market backdrop (Today): Core PPI m/m 1.3% vs 0.3% expected (hotter); Core Retail Sales m/m 0.9% vs 0.6% expected (stronger); S&P futures -0.08%, 10-year yield -3bp in the 30 minutes after.
Assembled from Wallsti's own signals and the session's headlines and filings read by AI (Claude); it can misread, so the sources are linked.
Technical rating
No technical rating for NVO yet; it is computed for S&P 500 components and stocks discussed on Reddit.
Ratings & grades
- Zacks rank
- —
- R500 rank today
- #88
- Overall R500 rank
- #404
- Grades: day · week · month · quarter · year
- ABEEE
Grades rank the stock's gain in each window against the S&P 500 components: S = better than all of them, A = top fifth, B, C, D, E = bottom fifth, F = worse than all.